Physician profile
John H Wagner
NPI 1487634085
$301.11
in general payments reported to CMS, 2019-2025
5 companies · $59.58 in 2025
The $59.58 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.23 · 2021: $12.49 · 2022: $149 · 2024: $21.45 · 2025: $59.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $43.25 · Food and Beverage: $37.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $43.25 |
| Food and Beverage | $37.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $176.96 | 2021-2025 | Enhertu |
| Sunovion Pharmaceuticals INC. | $73.68 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $21.45 | 2024 | Gemtesa |
| Otsuka America Pharmaceutical, INC. | $16.33 | 2025 | Rexulti |
| Avion Pharmaceuticals | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.